Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers

被引:21
作者
Arndt, MAE
Krauss, R
Rybak, SM
机构
[1] Univ Hosp Essen, Inst Immunol, D-45122 Essen, Germany
[2] NCI, SAIC, Frederick, MD 21702 USA
[3] NCI, Dev Therapeut Program, Frederick, MD 21702 USA
关键词
CD22; single chain Fv; diabody; dimer; stability;
D O I
10.1016/j.febslet.2004.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By varying linker length and domain orientation three multivalent derivatives of a monovalent anti-CD22 single-chain fragment variable (scFv) antibody were generated. Shortening the linker of the V-H-V-L oriented scFv to 5 or 0 residues resulted in the formation of diabodies or a mixture of tetramers and trimers, respectively. Unexpectedly, a V-L-0-V-H scFv assembled to homogenous dimers, remained substantially more stable than the V-H-5-V-L diabody when incubated in human serum at 37 degreesC, and retained its dimeric state when concentrated up to 4 mg/ml. These properties suggest the V-L-0-V-H scFv could become an attractive vehicle for the selective delivery of multiple effector molecules to CD22(+) tumor cells. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 32 条
[21]  
MILENIC DE, 1991, CANCER RES, V51, P6363
[22]  
Napier MP, 2000, CLIN CANCER RES, V6, P765
[23]  
Nielsen UB, 2000, CANCER RES, V60, P6434
[24]   ANATOMY OF THE ANTIBODY MOLECULE [J].
PADLAN, EA .
MOLECULAR IMMUNOLOGY, 1994, 31 (03) :169-217
[25]  
Pavlinkova G, 1999, J NUCL MED, V40, P1536
[26]   The 2.0-angstrom resolution crystal structure of a trimeric antibody fragment with noncognate V-H-V-L domain pairs shows are arrangement of V-H CDR3 [J].
Pei, XY ;
Holliger, P ;
Murzin, AG ;
Williams, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9637-9642
[27]   New protein engineering approaches to multivalent and bispecific antibody fragments [J].
Pluckthun, A ;
Pack, P .
IMMUNOTECHNOLOGY, 1997, 3 (02) :83-105
[28]   Noncovalent scFv multimers of tumor-targeting anti-Lewisy hu3S193 humanized antibody [J].
Power, BE ;
Doughty, L ;
Shapira, DR ;
Burns, JE ;
Bayly, AM ;
Caine, JM ;
Liu, ZQ ;
Scott, AM ;
Hudson, PJ ;
Kortt, AA .
PROTEIN SCIENCE, 2003, 12 (04) :734-747
[29]   Design and application of diabodies, triabodies and tetrabodies for cancer targeting [J].
Todorovska, A ;
Roovers, RC ;
Dolezal, O ;
Kortt, AA ;
Hoogenboom, HR ;
Hudson, PJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 248 (1-2) :47-66
[30]  
Willuda J, 1999, CANCER RES, V59, P5758